Security key
517125100
Larimar Therapeutics, Inc. - Common Stock, par value $0.001 per share (LRMR)
CUSIP: 517125100
Q3 2020 13F Holders as of 30 Sep 2020
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 13,625,016
- Total 13F value
- $206,745,000
- Share change
- +671,972
- SEC-reported price per share
- $15.17
- Number of holders
- 37
- Value change
- +$10,359,632
- Number of buys
- 17
- Number of sells
- 10
- Shares outstanding
- 107,502,422
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2020
Institutions
37
Top holders
10
LRMR full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Larimar Therapeutics, Inc. SEC filings
Larimar Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 517125100
Recent filing periods:
Ownership snapshot
Top reported holders of LRMR - Larimar Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
DEERFIELD MANAGEMENT COMP...
Disclosed value leader
DEERFIELD MANAGEMENT COMP...
Comparable rows
15/15
Latest evidence
30 Jun 2020
13F
Lead comparable stake: 4.8%
Showing 1-6 of 15 holder rows.
Quick read
DEERFIELD MANAGEMENT COMPANY, L.P. leads the comparable SEC ownership view at 4.8%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens DEERFIELD MANAGEMENT COMPANY, L.P.'s linked filing trail.
Comparable ownership
Top 5
DEERFIELD MANAGEMENT COMPANY, L.P.
4.8%
RA CAPITAL MANAGEMENT, L.P.
1.4%
CHI Advisors LLC
1.4%
ORBIMED ADVISORS LLC
0.87%
ACUTA CAPITAL PARTNERS, LLC
0.77%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
Company
|
4.8%
|
$66,107,000
5,144,539 shares
|
— | 30 Jun 2020 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
1.4%
|
$19,470,000
1,515,151 shares
|
— | 30 Jun 2020 |
| CHI Advisors LLC |
13F
Company
|
1.4%
|
$19,470,000
1,515,148 shares
|
— | 30 Jun 2020 |
| ORBIMED ADVISORS LLC |
13F
Company
|
0.87%
|
$12,001,000
933,960 shares
|
— | 30 Jun 2020 |
| ACUTA CAPITAL PARTNERS, LLC |
13F
Company
|
0.77%
|
$10,272,000
823,169 shares
|
— | 30 Jun 2020 |
| Vivo Capital, LLC |
13F
Company
|
0.74%
|
$10,276,000
799,662 shares
|
— | 30 Jun 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
37
Shares
13,625,016
Rows available
37
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2020 vs Q2 2020 Across Filers
Q2 2020 holders
34
Q3 2020 holders
37
Holder diff
3
| Investor | Q2 2020 Shares | Q3 2020 Shares | Share Diff | Share Chg % | Q2 2020 value | Q3 2020 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend